Revenue Jumps 50 Percent
Applied Nutrition Lifts Guidance As Revenue Jumps 50 Percent To £160 Million
Anonymous
Key Points
1
Analyst Wayne Brown of Panmure Liberum described Applied Nutrition as 'a clear brand winner' amid the FY2026 momentum, underscoring investor optimism about the brand’s growth trajectory.
2
Nutrablend is a vertically-integrated US subsidiary acquired in June, with a fully fitted-out facility in New York state capable of around $300m of capacity and its own R&D and design teams, underpinning capacity expansion plans.
3
The relaunch of Critical Whey in FY26 is highlighted as driving a greater whey-based product mix, which supports growth but is expected to dampen margins as whey costs rise and the US contribution grows.
4
TipRanks notes Applied Nutrition as an Outperform stock, supported by strong growth and catalysts, but cautions about near-term momentum and a relatively high P/E given no dividend yield.
Applied Nutrition, a Liverpool-based sports nutrition brand, smashed market expectations with revenue jumping 50% to £160 million in the year to July 31, 2026. Adjusted EBITDA climbed 40% to £43.3 million, beating forecasts and driving the stock up more than 6% Business Cloud.
The company raised FY27 guidance to £205 million in revenue and £49 million in adjusted EBITDA — continuing double-digit growth. Strong demand across markets and channels fueled the momentum, though margin pressure from rising whey protein costs and US expansion will moderate gains The Grocer.
Revenue Surge Backed by Global Demand
Applied Nutrition's £160 million revenue represented a sharp acceleration from £107 million the prior year. The jump came from sustained demand across multiple geographic markets and sales channels. Strong wholesale partnerships and brand recognition drove the outperformance Insider Media.
Analyst Wayne Brown of Panmure Liberum called Applied Nutrition 'a clear brand winner,' citing the company's momentum and global growth potential. The positive momentum has positioned the brand as a leader in the competitive sports nutrition sector Ask Traders.
Whey Protein Relaunch Drives Mix Shift
Applied Nutrition relaunched its Critical Whey product line during FY26, which boosted sales but shifted the product mix toward higher-margin whey-based items. The relaunch succeeded in growing revenue but brought exposure to commodity whey price volatility ADVFN.
Management expects whey costs to rise as US operations expand. This pressure will gradually compress margins in FY27 despite continued revenue growth. The company faces a trade-off: more whey products drive sales but reduce profit per unit sold The Grocer.
Nutrablend Acquisition Expands US Capacity
Applied Nutrition acquired Nutrablend in June 2026, gaining a fully fitted-out manufacturing facility in New York with capacity for around $300 million in annual output. The subsidiary brings its own R&D and design teams, accelerating product innovation Business Cloud.
Net cash reached £15.9 million at year-end after funding the Nutrablend deal and building new capacity. The robust cash position reflects strong operational cash generation, enabling further investment in growth Ask Traders.
FY27 Outlook Remains Above Consensus
Applied Nutrition guided FY27 revenue to £205 million and adjusted EBITDA to £49 million, beating many analyst forecasts. This represents continued double-digit growth despite headwinds from input costs and geographic mix ADVFN.
TipRanks rates Applied Nutrition as Outperform, citing strong growth catalysts. However, analysts caution that the high P/E valuation and lack of dividend yield leave little room for near-term disappointment Ask Traders.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
18
Articles
55
Reach
73
A
AnonymousAuthor
